Silk Therapeutics
2013
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series B
LATEST DEAL TYPE
$30M
LATEST DEAL AMOUNT
14
INVESTORS
Description
Provider of skincare products designed to enhance skin and diminish wrinkles. The company's products are made from pure liquid silk technology that offers effective stabilization and delivery of real silk molecules to the skin, with advanced anti-aging benefits, enabling consumers to use skincare products with no synthetic fillers, eliminating harsh preservatives.
Website
Formerly Known As
Silk Cosmetics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Internet Retail
Primary Office
- 196 Boston Avenue
- Suite 1100
- Medford, MA 02155
- United States
+1 (866) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Silk Therapeutics’s full profile, request a free trial.
Silk Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Early Stage VC (Series B) | 18-Oct-2018 | $30M | 000.00 | 00000 | Completed | Generating Revenue |
| 6. Early Stage VC | 000 | 000.00 | 0000 | Completed | Generating Revenue | |
| 5. Early Stage VC (Series A3) | 28-Sep-2017 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 4. Early Stage VC (Series A2) | 02-Feb-2016 | 000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Early Stage VC (Series A1) | 06-May-2015 | 000 | 00.000 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A1) | 27-Aug-2014 | $2M | $4.25M | 0000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 24-Mar-2014 | $1.2M | $1.2M | 00.000 | Completed | Generating Revenue |
Silk Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A4 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 4,066,664 | $0.000010 | $0.06 | $0.75 | $0.75 | 1x | $0.75 | 10.27% |
| Series A | 3,535,296 | $0.000010 | $0.03 | $0.34 | $0.34 | 1x | $0.34 | 8.93% |
Silk Therapeutics Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Jeff Vinik | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Highland Consumer Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Lear | Corporation | Minority | 000 0000 | 000000 0 | ||
| BML Group | Other | Minority | 000 0000 | 000000 0 | ||
| Erin Donahue | Angel (individual) | Minority | 000 0000 | 000000 0 |
Silk Therapeutics Executive Team (3)
Silk Therapeutics Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Brendan O'Leary Ph.D | Self | Board Member | 000 0000 | |
| Daniel Kraft | The Kraft Family Foundation | Board Member | 000 0000 | |
| Gregory Altman Ph.D | Silk Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Jeffrey Vinik | Self | Board Member | 000 0000 | |
| Roy Disney | Silk Therapeutics | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 7 board members. Get the full list »